About Fermentech GSV
Fermentech GSV is a Healthcare company based in Thanjavur (India) founded in 2017 by Sathyavrathan P. It operates as an anti-microbial peptides are supplied to biopharma and food industries. Its Indian entity Fermentech Gsv Private Limited reported revenue of ₹66.5 Lakh. Fermentech GSV offers products and services including GSV 234 and LOAFZYME. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Similar companies include Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group and 5 more; 8 of its 10 listed similar companies have raised funding.
Company details
Fermentech GSV was established in 2017 in Thanjavur, India, as a provider of anti-microbial peptides for biopharma and food processing sectors. The lead product, Nisin, is utilized in food preservation and anti-cancer applications within bio-pharma. Manufacturing operations are conducted in facilities certified by the FDA, ensuring compliance with regulatory standards for production and distribution.
- Headquarters Thanjavur, India
- Founders Sathyavrathan P
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website fermentechgsv.com
- Social LinkedIn
- Legal Name Fermentech Gsv Private Limited
- Date of Incorporation 24 May, 2017
- Jurisdiction Thanjavur, Tamil Nadu, India
- Annual Revenue₹66.5 Lakh
FY 2024 · +203% YoY
- Net Profit₹7.9 Lakh
FY 2024 · 12% margin
- EBITDA₹7.9 Lakh
FY 2024 · 12% margin
Associated legal entities of Fermentech GSV
Fermentech GSV operates through Fermentech Gsv Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Fermentech Gsv Private Limited CIN U24100TN2017PTC116737 | Active | 24 May 2017 | Thanjavur, Tamil Nadu | ₹0.7 Cr | – | 2 | View details |
Products & Services of Fermentech GSV
Fermentech GSV offers a comprehensive portfolio of products and services, including GSV 234 and LOAFZYME.
Formulation of Nisin to enhance shelf life of cheese and dairy products.
Fermentation-based alternative to bromides for improving bread quality.
Board of directors of Fermentech Gsv Private Limited (Fermentech GSV)
Fermentech Gsv Private Limited is the primary company behind Fermentech GSV. The board of Fermentech Gsv Private Limited currently have 2 directors; the longest-serving is Pathanjali Sathyavrathan, appointed in 2017. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pathanjali Sathyavrathan DIN 07815333 | Managing Director | 24 May 2017 | 9 yrs 4 mo | Fermentech Gsv Private Limited |
| Ramkrishnan Gopi DIN 07815312 | Director | 24 May 2017 | 9 yrs 4 mo | Fermentech Gsv Private Limited |
People of Fermentech GSV
1 people are tracked at Fermentech GSV (1 in leadership).
| Name | Role | Group |
|---|---|---|
Sathyavrathan P | Founder & Managing Director | Leadership |
Complete people profiles for Fermentech GSV
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Fermentech GSV
Figures of Fermentech Gsv Private Limited, the primary company behind Fermentech GSV, for FY 2024. Revenue was ₹66.5 Lakh (+203% year on year). Net profit was ₹7.9 Lakh (12% margin). EBITDA was ₹7.9 Lakh (12% margin). Revenue has grown at a compounded annual rate of +62% over three years.
- ₹66.5 LakhRevenue · FY 2024 · +203% YoY
- ₹7.9 LakhNet profit · 12% margin
- ₹7.9 LakhEBITDA · 12% margin
- ₹15 LakhPaid-up capital
- +62%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Fermentech Gsv Private Limited are on its company page.
Detailed financial statements for Fermentech GSV
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Fermentech GSV
Fermentech GSV has 10 listed similar companies in our database, 8 of them funded. They include Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| judges.uk.com | 2002 | London, United Kingdom | – | 622 | Acquisition and development of scientific instrument businesses is conducted. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed similar companies of Fermentech GSV
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Fermentech GSV (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Fermentech GSV
Fermentech GSV was founded in 2017.
Fermentech GSV is headquartered in Thanjavur, India. It is registered at Thanjavur, Tamil Nadu, India.
The primary company behind Fermentech GSV, Fermentech Gsv Private Limited, reported revenue of ₹66.5 Lakh for FY 2024, up 203% year on year.
Fermentech GSV was established in 2017 in Thanjavur, India, as a provider of anti-microbial peptides for biopharma and food processing sectors. The lead product, Nisin, is utilized in food preservation and anti-cancer applications within bio-pharma. Manufacturing operations are conducted in facilities certified by the FDA, ensuring compliance with regulatory standards for production and distribution.
Fermentech GSV's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Fermentech GSV offers GSV 234 and LOAFZYME.
Fermentech GSV operates through Fermentech Gsv Private Limited.
The legal entities of Fermentech GSV currently have 2 directors, including Pathanjali Sathyavrathan, Ramkrishnan Gopi.